Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection.
10.1007/s13238-020-00778-8
- Author:
Wanyin TAO
1
;
Xiaofang WANG
1
;
Guorong ZHANG
2
;
Meng GUO
2
;
Huan MA
2
;
Dan ZHAO
2
;
Yong SUN
3
;
Jun HE
3
;
Lianxin LIU
1
;
Kaiguang ZHANG
1
;
Yucai WANG
1
;
Jianping WENG
1
;
Xiaoling MA
4
;
Tengchuan JIN
5
;
Shu ZHU
6
Author Information
1. The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
2. Hefei National Laboratory for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
3. Key Laboratory for Medical and Health of the 13th Five-Year Plan, Anhui Provincial Center for Disease Control and Prevention, Hefei, China.
4. The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. maxiaoling@ustc.edu.cn.
5. Hefei National Laboratory for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. Jint@ustc.edu.cn.
6. The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. zhushu@ustc.edu.cn.
- Publication Type:Research Support, Non-U.S. Gov't
- MeSH:
Adult;
Antibodies, Viral/isolation & purification*;
COVID-19/virology*;
Feces/chemistry*;
Female;
Humans;
Intestines/virology*;
Male;
RNA, Ribosomal, 16S/genetics*;
RNA, Viral/isolation & purification*;
SARS-CoV-2/pathogenicity*
- From:
Protein & Cell
2021;12(3):230-235
- CountryChina
- Language:English
